![](https://imgproxy.divecdn.com/P93gorq5bVU2HF2V3uOIW7AomOc23VwRdq9wE2kNclg/g:nowe:0:20/c:2554:1442/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9FZHdhcmRfS2F5ZV9TdG9rZV9UaGVyYXBldXRpY3MuanBn.webp)
Biogen buys rights to Stoke’s rare epilepsy drug
Dive Brief: Through a new deal, Biogen has bought access to a potentially first-of-its-kind drug that some doctors and analysts see as a promising treatment for a rare form of epilepsy. Biogen on Tuesday agreed to pay $165 million upfront for exclusive …